Balyasny Asset Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-109,003
| Closed | -$653K | – | 2075 |
|
|
2025
Q1 | $653K | Buy |
109,003
+88,198
| +424% | +$528K | ﹤0.01% | 1497 |
|
|
2024
Q4 | $162K | Buy |
20,805
+1,687
| +9% | +$13.2K | ﹤0.01% | 1766 |
|
|
2024
Q3 | $206K | Sell |
19,118
-25,323
| -57% | -$273K | ﹤0.01% | 1782 |
|
|
2024
Q2 | $375K | Buy |
+44,441
| New | +$375K | ﹤0.01% | 1546 |
|
|
2023
Q4 | – | Sell |
-125,638
| Closed | -$1.22M | – | 1966 |
|
|
2023
Q3 | $1.22M | Buy |
+125,638
| New | +$1.22M | ﹤0.01% | 1105 |
|
|
2023
Q2 | – | Sell |
-19,974
| Closed | -$216K | – | 1922 |
|
|
2023
Q1 | $216K | Buy |
+19,974
| New | +$216K | ﹤0.01% | 1769 |
|
|
2022
Q4 | – | Sell |
-1,049,542
| Closed | -$15.7M | – | 2377 |
|
|
2022
Q3 | $15.7M | Sell |
1,049,542
-51,761
| -5% | -$772K | 0.05% | 418 |
|
|
2022
Q2 | $9.93M | Buy |
+1,101,303
| New | +$9.93M | 0.03% | 535 |
|